Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Comparison of performance of two clinical scales to assess the post-thrombotic syndrome: Secondary analysis of a multicenter RCT of pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis
EF 2018-19
Résumé
Finding the scoring system that best captures the doctor's evaluation and the individual's experience of the long term complications of blood clots
In Canada, up to 90,000 people per year are affected by blood clots. Blood clots are treated using blood-thinning medications called anticoagulants. In certain cases, doctors may use a more intensive "clot busting treatment" involving a procedure to deliver clot dissolving medication near the clot and actively remove the clot. Despite treatment, 20-50% of people with blood clots face long term complications, notably post-thrombotic syndrome (PTS). PTS consists of pain, redness and swelling that occur 6 months or later after the initial blood clot. Two measures, the Villalta scale and the Venous Clinical Severity Score (VCSS) can diagnose and asses the severity of PTS. They capture two separate lists of problems seen in PTS reflecting the doctor's evaluation and the individual's experience. My project will look at 692 study participants at 56 U.S hospitals from the previously published ATTRACT trial, which examined whether the "clot busting treatment" was better at preventing PTS compared to anticoagulants alone. Throughout the ATTRACT trial, the Villalta scale and the VCSS questionnaires were used to detect PTS and follow its changes during the study. Concurrently, the participants completed questionnaires about the impact of PTS on their quality of life (QoL). My research aim is to determine the relationship of the more objective scores of the Villalta scare and VCSS, to the subjective experience depicted through the QoL questionnaires. I will thereby determine which measure best captures PTS and PTS severity over time, which will greatly help researchers and doctors in this field as well as individuals affected by PTS.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
416078
Name
Lee Angela Y
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Comparison of performance of two clinical scales to assess the post-thrombotic syndrome: Secondary analysis of a multicenter RCT of pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Post Thrombotic Syndrome; Deep Vein Thrombosis; Diagnostic Scales; Thrombosis; Venous Clinical Severity Score; Villalta Score
Abstract
Finding the scoring system that best captures the doctor's evaluation and the individual's experience of the long term complications of blood clots
In Canada, up to 90,000 people per year are affected by blood clots. Blood clots are treated using blood-thinning medications called anticoagulants. In certain cases, doctors may use a more intensive "clot busting treatment" involving a procedure to deliver clot dissolving medication near the clot and actively remove the clot. Despite treatment, 20-50% of people with blood clots face long term complications, notably post-thrombotic syndrome (PTS). PTS consists of pain, redness and swelling that occur 6 months or later after the initial blood clot. Two measures, the Villalta scale and the Venous Clinical Severity Score (VCSS) can diagnose and asses the severity of PTS. They capture two separate lists of problems seen in PTS reflecting the doctor's evaluation and the individual's experience. My project will look at 692 study participants at 56 U.S hospitals from the previously published ATTRACT trial, which examined whether the "clot busting treatment" was better at preventing PTS compared to anticoagulants alone. Throughout the ATTRACT trial, the Villalta scale and the VCSS questionnaires were used to detect PTS and follow its changes during the study. Concurrently, the participants completed questionnaires about the impact of PTS on their quality of life (QoL). My research aim is to determine the relationship of the more objective scores of the Villalta scare and VCSS, to the subjective experience depicted through the QoL questionnaires. I will thereby determine which measure best captures PTS and PTS severity over time, which will greatly help researchers and doctors in this field as well as individuals affected by PTS.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lee, Angela Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~